Physician profile
Sarah Serb
NPI 1780162370
$7,053.22
in general payments reported to CMS, 2019-2025
35 companies · $746 in 2025
The $746 reported for 2025 was more than what 83% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,466 · 2022: $1,046 · 2023: $2,409 · 2024: $1,386 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,816 · Travel and Lodging: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,815.62 |
| Travel and Lodging | $725.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $2,405.83 | 2022-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Glaxosmithkline, LLC. | $950.96 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $715.56 | 2021-2025 | Fasenra, Airsupra, Breztri |
| United Therapeutics Corporation | $347.00 | 2021-2025 | Remodulin, Orenitram, Remodulin |
| Actelion Pharmaceuticals US, INC. | $330.23 | 2021-2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $307.43 | 2021-2024 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Jazz Pharmaceuticals INC. | $278.00 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $242.87 | 2021-2024 | Dupixent |
| Amgen INC. | $138.34 | 2022-2024 | Tezspire |
| Genzyme Corporation | $137.63 | 2021-2024 | |
| Mylan Specialty L.P. | $120.03 | 2021-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $97.58 | 2021-2025 | Glassia |
| Merck Sharp & Dohme LLC | $97.49 | 2021-2024 | Winrevair, Keytruda |
| Insmed, INC. | $95.42 | 2024-2025 | Arikayce |
| Teva Pharmaceuticals USA, INC. | $94.24 | 2021-2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $83.53 | 2022-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Electromed, INC. | $77.60 | 2021-2023 | Smartvest |
| Bayer Healthcare Pharmaceuticals INC. | $61.61 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $52.38 | 2024 | Acthar |
| Vanda Pharmaceuticals INC. | $42.85 | 2021 | |
| Inspire Medical Systems, INC. | $41.71 | 2025 | Inspire |
| Harmony Biosciences LLC | $36.59 | 2023 | Wakix |
| Philips North America LLC | $36.14 | 2022-2023 | |
| Advanced Respiratory, INC | $34.94 | 2021 | |
| Pfizer INC. | $32.39 | 2022-2023 | |
| Grifols USA, LLC | $30.15 | 2023 | Prolastin-C Liquid |
| Sunovion Pharmaceuticals INC. | $24.78 | 2021 | |
| Abbvie INC. | $22.28 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.25 | 2022 | |
| Astellas Pharma US INC | $18.68 | 2023 | Cresemba |
| Avadel Cns Pharmaceuticals, LLC | $18.25 | 2024 | Lumryz |
| Viatris Specialty LLC | $15.74 | 2025 | Yupelri |
| Ani Pharmaceuticals, INC. | $15.09 | 2025 | Purified Cortrophin Gel |
| Fisher & Paykel Healthcare INC | $15.09 | 2023 | Fisher & Paykel Healthcare |
| Eisai INC. | $14.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Serb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.